trivalent live-attenuated influenza vaccine
Term · Oncology and biomedicine · MLC-T-ONC-017335
A weakened live virus vaccine containing three seasonal influenza reassortants with prophylactic activity against influenza subtypes A and B. The trivalent live-attenuated influenza vaccine (LAIV) contains 2 strains of the influenza subtype A, one for H1N1 and one for H3N2, and one strain of subtype B. Upon intranasal administration by sprayer of the trivalent LAIV, the live viruses replicate in the upper respiratory tract and induce an immune response leading to active immunization against influenza subtypes A and B.
| Identifier | MLC-T-ONC-017335 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | trivalent intranasal influenza vaccine, live |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017335",
"term": "trivalent live-attenuated influenza vaccine",
"field": "Oncology and biomedicine",
"definition": "A weakened live virus vaccine containing three seasonal influenza reassortants with prophylactic activity against influenza subtypes A and B. The trivalent live-attenuated influenza vaccine (LAIV) contains 2 strains of the influenza subtype A, one for H1N1 and one for H3N2, and one strain of subtype B. Upon intranasal administration by sprayer of the trivalent LAIV, the live viruses replicate in the upper respiratory tract and induce an immune response leading to active immunization against influenza subtypes A and B.",
"synonyms": [
"trivalent intranasal influenza vaccine, live"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/trivalent-live-attenuated-influenza-vaccine/"
}
Record 16,745 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.